2010. USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS. Mediterranean Journal of Hematology and Infectious Diseases. 2, 1 (Mar. 2010), e2010003. DOI:https://doi.org/10.4084/mjhid.2010.003.